Shots: The 7 studies include one Proffered Paper Oral Presentation & 6 e-posters, covering indications including lung cancer, liver cancer, gastric cancer, & esophageal cancer The 1st study involves assessing […]readmore
Tags : Asia
DigiHealth
Regulatory
World’s First App-Based Nicotine Addiction Treatment Receives the MHLW’s Approval
Shots: On Aug 21, 2020, CureApp receives MHLW’s approval for the manufacturing and sale of Asia’s first therapeutics app, the “CureApp SC Nicotine Addiction Treatment App and CO Checker’’. The […]readmore
Shots: The launch of Bayer-MassCONNECT Asia will support the startup community in Asia with a special focus on China. The collaboration of two companies will integrate MassBio’s mentoring expertise with […]readmore
Shots: Alvotech will be responsible for the development and supply of AVT02 in selected APAC market, while DKSH will be responsible for the registration and commercialization of the therapy The […]readmore
Shots: Alopexx to receive up front, development & commercialization milestones along with royalties on sales. Beijing Shenogen Pharma get an exclusive license to develop & commercialize DI-Leu16-IL2 in China and […]readmore
Shots: Astellas to receive ~$88.3M as up front for its three products. Daiichi to get rights and obligations, including manufacturing and marketing approvals for Nasea (ramosetron), Perdipine (nicardipine) and Oldeca […]readmore
Shots: Medigene to receive $10M upfront, $1B as development, regulatory, and commercial milestones & royalties on sales of four products in multiple indications. Cytovant to get exclusive development & commercialization […]readmore